The review found that the vaccine met the must-have criteria for safety and efficacy set out by WHO.
The World Health Organization (WHO) has listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.
Read alsoSwissmedic approves Pfizer/BioNTech vaccine
"The review found that the vaccine met the must-have criteria for safety and efficacy set out by WHO, and that the benefits of using the vaccine to address COVID-19 offset potential risks," reads the report.